Loading…
← CockpitCompetitor Analysis › ADVENZYMES.NS Advanced Enzyme Technologies LtdOpen in the cockpit ↗

Advanced Enzyme Technologies LtdADVENZYMES.NSCompetitor analysis, valuation and peers

India · INR·FMCG›Food: Specialty/Candy
Momentum weak 28
Mkt cap
$333M
US dollars, full cap
Free float
30%
of shares outstanding
$/day
$763,369
20-day average traded
Fwd P/E
18.9×
forward earnings
ROIC−WACC
-3.3 pp
WACC 15.9%
Hurdle
+11 pp
Req g minus delivered
Next earnings
94 days
8 Feb 2027
Close · INR₹280.30
1D-1.4%
1W+6.4%
1M+3.8%
3M-15.0%
6M-22.1%
YTD-7.3%
1Y-9.7%
ATR %3.6%
Beta1.00
52w lowhigh33.1% off high

What Advanced Enzyme Technologies does

Employees: 762

Advanced Enzyme Technologies at a glance

Size Advanced Enzyme Technologies (ADVENZYMES.NS) is an India Consumer Staples company (Food: Specialty/Candy) with a market value of $333M, the 1009th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹280.30 on 6 Nov 2026.

Performance Over six months the shares fell 22.1%, against -9.3% for the median peer and 0.0% for the India market (cap-weighted) — 9th lowest of 21 in its peer set.

Growth Revenue grew 10.3% over the last twelve months (peer median +6.9%); the operating margin is 24.9% (peer median 5.8%).

Valuation It trades at 18.9× forward earnings against a peer median of 18.5× (6th most expensive of 12).

Price implies For today's price to make sense, revenue must grow about 19% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +11 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 3.3 points below its cost of capital (15.9% WACC).

Next results Next results expected around 8 Feb 2027 (exchange calendar; dates can move).

Relative performance

8010011 May 202611 Aug 20266 Nov 2026Peer median 91ADVENZYMES.NS 78
Six months, rebased to 100: Advanced Enzyme Technologies against the median of its 20 peers (local-currency closes).

Advanced Enzyme Technologies financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹7.80B₹7.45B₹6.37B₹6.23B₹5.40B
Revenue growth—+17%+2%+15%—
Gross profit₹3.66B₹2.74B₹2.40B₹2.46B₹1.97B
EBITDA₹2.36B₹2.32B₹1.97B₹2.07B₹1.65B
Net income₹1.71B₹1.69B₹1.31B₹1.33B₹1.06B
Free cash flown/a₹1.20B₹1.15B₹1.09B₹1.08B
Capital expendituren/a₹524M₹348M₹473M₹382M
Total debt₹537M₹320M₹394M₹473M₹335M

Quarterly statements and history in the cockpit →

Advanced Enzyme Technologies competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%-40%-20%0%0411P34GOPAL00266122072226BONOFRM122640ADFFOODS000972603755Q010027723012202723YASHO300673ADVENZYMES.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Advanced Enzyme Technologies is the large dot.

Fundamentals: revenue growth against valuation

-10%0%+10%+20%20×40×P34GOPAL2207BON122640ADFFOODS60375530122027238079300673ADVENZYMES.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Advanced Enzyme Technologies is the large dot.

Capital: growth delivered against growth the price implies

0%+25%+50%+75%0%50%P34002661000972603755Q013012202723YASHO300673ADVENZYMES.NSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Advanced Enzyme Technologies is the large dot.

Advanced Enzyme Technologies competitors and peer comparison

How Advanced Enzyme Technologies compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Advanced Enzyme Technologies against its 20 peers (data as of 6 Nov 2026)
MeasureADVENZYMES.NSPeer medianRank in peer set
1-month return+3.8%-6.0%2nd highest of 21
6-month return-22.1%-9.3%9th lowest of 21
Distance from 52-week high-33.1%-30.8%9th lowest of 21
Revenue growth (TTM)+10.3%+6.9%9th highest of 21
Operating margin24.9%5.8%highest of 21
Forward P/E18.9×18.5×6th most expensive of 12
Growth the price implies (Req g, 7 yrs)19.1%-1.1%3rd most demanding of 11
Growth delivered (Del g)+8.3%+3.3%5th highest of 11
Hurdle (Req g minus delivered)+10.8 pp-2.6 pp2nd most demanding of 11
ROIC minus cost of capital-3.3 pp-0.2 pp7th lowest of 21
EV / EBITDA10.9×9.3×7th most expensive of 15
Net debt / EBITDA-2.6×0.9×3rd least indebted of 15

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Advanced Enzyme Technologies ADVENZYMES.NSIndia$333M-22%+10%25%18.9×19.1%+8.3%
Lam Soon (Hong Kong) 0411.HKHong Kong$330M-4%+5%6%n/an/an/a
Delfi P34.SISingapore$328M-34%-2%7%10.5×-12.8%+4.2%
Gopal Snacks GOPAL.NSIndia$324M-26%+20%5%40.9×n/an/a
Chen Ke Ming Food Manufacturing 002661.SZChina$342M-22%0%-2%n/a-3.0%+1.9%
Meito 2207.TJapan$342M+3%+3%3%12.0×n/an/a
KOIKE-YA 2226.TJapan$321M+2%+3%7%n/an/an/a
Bonduelle SCA BON.PAFrance$294M0%-1%4%6.8×-3.4%+0.2%
Once Upon a Farm, PBC OFRMUnited States$389M-43%+43%-6%n/an/an/a
YEST 122640.KSSouth Korea$283M-32%+10%6%18.5×n/an/a
Fujiya 2211.TJapan$393M-1%+6%1%n/an/an/a
ADF Foods ADFFOODS.NSIndia$280M-10%+19%16%19.2×n/an/a
Chalkis Health Industry 000972.SZChina$397M-9%+17%-52%n/a-6.8%+89.3%
Qingdao Richen Food 603755.SSChina$407M-5%+11%17%33.2×20.1%+12.3%
QAF Q01.SISingapore$408M-10%0%6%n/a-10.6%+2.4%
Tianshui Zhongxing Bio-Technology 002772.SZChina$410M-54%+12%14%n/an/an/a
Kunshan Asia Aroma 301220.SZChina$413M-35%+13%6%24.8×10.8%+12.4%
Gourmet Master 2723.TWTaiwan$431M+19%-11%5%14.8×0.9%-1.7%
Shoei Foods 8079.TJapan$435M+1%+8%4%17.6×n/an/a
Yasho Industries YASHO.NSIndia$441M+122%+35%14%n/a33.4%+17.7%
Petpal Pet Nutrition Technology 300673.SZChina$444M-26%+2%6%45.6×7.5%+1.6%

Questions

Which companies are Advanced Enzyme Technologies's closest peers?
The cockpit's peer set: Lam Soon (Hong Kong) (0411.HK), Delfi (P34.SI), Gopal Snacks (GOPAL.NS), Chen Ke Ming Food Manufacturing (002661.SZ), Meito (2207.T), KOIKE-YA (2226.T), Bonduelle SCA (BON.PA), Once Upon a Farm, PBC (OFRM).
Is Advanced Enzyme Technologies expensive compared with its peers?
On forward p/e it trades at 18.9× against a peer median of 18.5×, 6th most expensive of 12 in its peer set. For today's price to make sense, revenue must grow about 19% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is +11 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Advanced Enzyme Technologies stock performed?
Over six months to 6 Nov 2026 the shares returned -22.1% against -9.3% for the median peer; over one year -9.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.